Latest Cost Reduction News

CL8 Holdings has sharply reduced expenses following office closure and is actively exploring new growth sectors including AI, B2B SaaS, EdTech, and Cybersecurity while maintaining its stake in the expanding car subscription market.

Securelink Networks has increased its stake in the PT&T joint venture to 50.1%, securing effective control, while its VSN Plus product gains strong traction in the Philippine market. The company also advances its ASX re-listing efforts amid ongoing cost reductions.

Axtec Limited maintains a steady cash position through strategic equity placements and cost reductions while advancing its PropTech platform and partnerships.

Quantum Graphite has extended its Uley 2 Project mining leases for 21 years, underpinning long-term development plans while showcasing its innovative TES Graphite Cells technology at a major energy conference. Financing discussions are progressing to potentially integrate downstream processing, signalling a pivotal phase for the company.

Oldfields Holdings reports steady progress in its turnaround strategy, cutting costs and reallocating assets to stronger regions while preparing for a capital raise and potential acquisitions.

TasFoods reported a 9.6% revenue decline in Q4 2025 amid oversupply and discounted mainland poultry impacting Tasmanian markets, while completing the sale of Pyengana Dairy.

Astron Limited has advanced its Donald Rare Earth and Mineral Sands Project with conditional senior debt support and ongoing financing discussions, targeting a final investment decision by the end of March 2026.

KNeoMedia advances its KneoScience platform with new orders and high school expansion, while actively working to lift its ASX trading suspension through cost cuts and funding initiatives.

Burley Minerals is progressing its Cane Bore Iron Project with planned drilling following heritage surveys, while reviewing its Chubb Lithium Project strategy amid rising lithium prices. The company also relinquished its Yerecoin Iron Project due to legal challenges.

Pathkey.AI has completed a strategic review, bolstered its leadership team, and secured $3.5 million in funding to accelerate growth and broaden its AI platform's applications beyond clinical trials.

Vectus Biosystems is close to finalising a $4.3 million transaction with Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its anti-fibrotic drug candidates amid cost reductions.

Babylon Pump & Power has reported a robust December quarter, driven by strong rental segment performance and a significant new contract with Newmont. Despite challenges in its maintenance division, the company is positioned for growth with fresh leadership and strategic asset management.